Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trialEvan S. Dellon, Ikuo Hirano, Chinyu Su et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 15